This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioProcess International
Mark Your Calendar for Next Year's Event!
September 18-21, 2023Boston Convention and Exhibition Center

Phil Morton
Chief Technology Officer at Albumedix Ltd

Profile

Dr Philip Morton has a strong technology background with over 25 years’ experience in the biopharmaceutical industry within process and product development as well as product application research. He was trained as a biochemical engineer and has biopharmaceutical experience in both R&D and manufacturing environments in Albumedix under its former owners of Delta Biotechnology, Aventis and Novozymes. He current heads up biotechnology innovation within Albumedix in both the production and use of its’ products.

Agenda Sessions

  • STOP AND RETHINK! Don’t Settle With A Narrow Cell Viability Window; Take Back Stability Control of Your Cell Therapy

    1:55pm